InVivoMAb anti-human/monkey CD40L (CD154)
BE0292
ApplicationsFlow Cytometry, ImmunoPrecipitation, Neutralisation/Blocking
Product group Antibodies
Overview
- SupplierBio X Cell
- Product NameInVivoMAb anti-human/monkey CD40L (CD154)
- Delivery Days Customer7
- ApplicationsFlow Cytometry, ImmunoPrecipitation, Neutralisation/Blocking
- CertificationResearch Use Only
- ClonalityMonoclonal
- Clone ID5C8
- Concentration4-11 mg/ml
- Estimated Purity>95%
- HostMouse
- IsotypeIgG2a
- Storage Instruction2°C to 8°C
- UNSPSC12352203
References
- Nadazdin O, Boskovic S, Wee SL, et al. Contributions of direct and indirect alloresponses to chronic rejection of kidney allografts in nonhuman primates. J Immunol. 2011,187(9):4589-97. doi: 10.4049/jimmunol.1003253Read this paper
- Jabara HH, Brodeur SR, Geha RS. Glucocorticoids upregulate CD40 ligand expression and induce CD40L-dependent immunoglobulin isotype switching. J Clin Invest. 2001,107(3):371-8.Read this paper
- Singh J, Garber E, Van Vlijmen H, et al. The role of polar interactions in the molecular recognition of CD40L with its receptor CD40. Protein Sci. 1998,7(5):1124-35.Read this paper
- Grammer AC, Bergman MC, Miura Y, et al. The CD40 ligand expressed by human B cells costimulates B cell responses. J Immunol. 1995,154(10):4996-5010.Read this paper
- Yellin MJ, Brett J, Baum D, et al. Functional interactions of T cells with endothelial cells: the role of CD40L-CD40-mediated signals. J Exp Med. 1995,182(6):1857-64.Read this paper
